| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |